Co-op, Systems Engineering: January-June 2027 (Hybrid)

Job Summary: Co-op, Systems Engineering: January-June 2027 (Hybrid) Position Dates: January 11, 2027 – June 30, 2027 Job Title: Co-op, Systems Engineering Department: 6730 – Systems COE FLSA Status: Non-Exempt Position Overview: The Systems Engineering team is a fast growing, creative and motivated group of engineers consisting of several engineering disciplines. These disciplines include, but are not limited to biomedical, mechanical, and electrical engineering. The team's primary focus within R&D is ensuring all new product innovations are safe, effective, and satisfy requirements for the final product utilized by the end user. The systems team works hand in hand with several other groups within the R&D organization to drive all aspects of the design and development process including alignment on high and low level product requirements, risk management analysis, design verification, traceability, and creation of the Device Master Record. At Insulet, co-ops are considered entry level engineers. This position is designed to provide the selected candidate with a broad exposure to the design and development process for medical devices that are used by patients around the world on a daily basis. This position will be an integral member of the R&D team directly supporting the product development phases of Insulet's innovation pipeline of wearable pump technology. This role will provide exposure to several aspects of Insulet's design control processes including but not limited to writing and interpreting product requirements, device integration, verification test methods, troubleshooting/design analysis, and design documentation.

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com. We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it! At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.(Know Your Rights)